Profound Medical (TSE:PRN) Shares Up 0.3%

Profound Medical Corp. (TSE:PRN) shares shot up 0.3% during mid-day trading on Monday . The company traded as high as C$10.92 and last traded at C$10.76. 5,830 shares changed hands during mid-day trading, a decline of 18% from the average session volume of 7,076 shares. The stock had previously closed at C$10.73.

Profound Medical Price Performance

The company has a 50 day moving average price of C$12.34 and a 200 day moving average price of C$11.64. The company has a current ratio of 8.61, a quick ratio of 14.98 and a debt-to-equity ratio of 16.95. The company has a market capitalization of C$269.77 million, a P/E ratio of -6.47 and a beta of 0.83.

Profound Medical (TSE:PRN) last issued its quarterly earnings data on Thursday, August 8th. The company reported C($0.38) earnings per share for the quarter, meeting the consensus estimate of C($0.38). The company had revenue of C$3.06 million during the quarter, compared to the consensus estimate of C$3.42 million. On average, equities analysts predict that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year.

Insider Transactions at Profound Medical

In other news, Senior Officer Rashed Osman Dewan acquired 9,765 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were purchased at an average cost of C$12.85 per share, with a total value of C$125,480.25. Corporate insiders own 8.66% of the company’s stock.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.